Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EARLY: Early Clozapine vs Olanzapine in Acute Schizophrenia
2018-001514-15Phase 3Terminated
- Sponsor
- Bezirkskliniken Schwaben
- Start
- Sep 2018
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in schizophrenia comparing Early clozapine with Olanzapine (2 arms). Primary endpoint: Symptomatic remission at week 8. Started Sep 2018; status: terminated.
02
Drugs
clozapineolanzapine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on 2018-001514-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-001514-15.